TiGenix to present at Cowen’s 37th Annual Health Care Conference in Boston – EconoTimes
Posted: March 1, 2017 at 6:42 pm
Wednesday, March 1, 2017 6:01 AM UTC
PRESS RELEASE
TiGenix to present at Cowen's 37thAnnual Health Care Conference in Boston
Leuven (BELGIUM) - 1st March, 2017, 07:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG), an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic expanded stem cells, today announced that Eduardo Bravo, CEO of TiGenix, will be presenting at the 37th Annual Cowen and Company's Health Care Conference in Boston (USA) at The Boston Marriott Copley Place on Monday, March 6 at 3:20-3:50PM (EST) in Regis, 3rd Floor (breakout at 4:00 PM-04:30PM (EST) at Boston University, 3rd Floor).
The presentation will be webcast live and can be accessed on the day of the event at this link. A replay of the webcast will be available on the Company's website for 30 days following the presentation. To ensure timely connection, it is recommended that users register at least 10 minutes prior to the scheduled webcast.
The TiGenix management team will be available for one-to-one meetings from Monday, March 6th to Wednesday, March 8th. Please contact Investor Relations at Investor@tigenix.com for a meeting request.
For more information:
Claudia D'Augusta Chief Financial Officer T: +34 91 804 92 64 claudia.daugusta@tigenix.com
About TiGenix
TiGenix NV (Euronext Brussels: TIG) is an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic, or donor-derived, expanded stem cells. Our lead product candidate from the adipose-derived stem cell technology platform is Cx601, which is in registration with the European Medicines Agency for the treatment of complex perianal fistulas in Crohn's disease patients. Our adipose-derived stem cell product candidate Cx611 has completed a Phase I sepsis challenge trial and a Phase I/II trial in rheumatoid arthritis. Effective July 31, 2015, TiGenix acquired Coretherapix, whose lead cellular product candidate, AlloCSC-01, is currently in a Phase II clinical trial in Acute Myocardial Infarction (AMI). In addition, the second product candidate from the cardiac stem cell-based platform acquired from Coretherapix, AlloCSC-02, is being developed in a chronic indication. On July 4, 2016, TiGenix entered into a licensing agreement with Takeda, a large pharmaceutical company active in gastroenterology, under which Takeda acquired the exclusive right to commercialize Cx601 for complex perianal fistulas outside the United States. TiGenix is headquartered in Leuven (Belgium) and has operations in Madrid (Spain).
About Cx601
Cx601 is a suspension of allogeneic expanded adipose-derived stem cells (eASC) locally injected. Cx601 is an investigational agent being developed for the treatment of complex perianal fistulas in Crohn's disease patients with inadequate response to at least one conventional or biologic therapy including antibiotics, immunosuppressants, or anti-TNF agents. Crohn's disease is a chronic inflammatory disease of the intestine and patients can suffer from complex perianal fistulas for which there is currently no effective treatment. In 2009, the European Commission granted Cx601 orphan designation for the treatment of anal fistulas, recognizing the debilitating nature of the disease and the lack of treatment options. Cx601 has met the primary end-point in the Phase III ADMIRE-CD study in Crohn's disease patients with complex perianal fistula, a randomized, double-blind, placebo-controlled trial run in Europe and Israel and designed to comply with the requirements laid down by the EMA. 'Madrid Network' issued a soft loan to help finance this Phase III study, which was funded by the Secretary of State for Research, Development and Innovation (Ministry of Economy and Competitiveness) within the framework of the INNTEGRA plan. The study's primary endpoint was combined remission, defined as clinical assessment at week 24 of closure of all treated external openings draining at baseline despite gentle finger compression, and absence of collections >2cm confirmed by MRI. In the ITT population (n=212), Cx601 achieved statistically significant superiority (p=0.024) on the primary endpoint with 50% combined remission at week 24 compared to 34% in the placebo arm. Efficacy results were robust and consistent across all statistical populations. Treatment emergent adverse events (non-serious and serious) and discontinuations due to adverse events were comparable between Cx601 and placebo arms. The 24-weeks results have been published by The Lancet, one of the most highly regarded and well known medical journals in the world. The Phase III study has completed a follow-up analysis at 52 weeks confirming its sustained efficacy and safety profile. Top line follow-up data showed that in the ITT population Cx601 achieved statistical superiority (p=0.012) with 54% combined remission at week 52 compared to 37% in the placebo arm. The 52-week data also showed a higher rate of sustained closure in those patients treated with Cx601 and in combined remission at week 24 (75.0%) compared to patients in the placebo group (55.9%). Based on the positive 24-weeks Phase III study results, TiGenix has submitted a Marketing Authorization Application to the EMA in early 2016. TiGenix is preparing to develop Cx601 in the U.S. after having reached an agreement with the FDA through a special protocol assessment procedure (SPA) in 2015. On July 4, 2016 TiGenix entered into a licensing agreement with Takeda, a pharmaceutical company leader in gastroenterology, whereby Takeda acquired an exclusive right to commercialize Cx601 for complex perianal fistulas in Crohn's patients outside of the U.S.
Forward-looking information
This press release may contain forward-looking statements and estimates with respect to the anticipated future performance of TiGenix and the market in which it operates. Certain of these statements, forecasts and estimates can be recognised by the use of words such as, without limitation, "believes", "anticipates", "expects", "intends", "plans", "seeks", "estimates", "may", "will" and "continue" and similar expressions. They include all matters that are not historical facts. Such statements, forecasts and estimates are based on various assumptions and assessments of known and unknown risks, uncertainties and other factors, which were deemed reasonable when made but may or may not prove to be correct. Actual events are difficult to predict and may depend upon factors that are beyond the Company's control. Therefore, actual results, the financial condition, performance or achievements of TiGenix, or industry results, may turn out to be materially different from any future results, performance or achievements expressed or implied by such statements, forecasts and estimates. Given these uncertainties, no representations are made as to the accuracy or fairness of such forward-looking statements, forecasts and estimates. Furthermore, forward-looking statements, forecasts and estimates only speak as of the date of the publication of this press release. TiGenix disclaims any obligation to update any such forward-looking statement, forecast or estimates to reflect any change in the Company's expectations with regard thereto, or any change in events, conditions or circumstances on which any such statement, forecast or estimate is based, except to the extent required by Belgian law.
Human Life Could Be Extended Indefinitely, Study Suggests
Goosebumps, tears and tenderness: what it means to be moved
Are over-the-counter painkillers a waste of money?
Does an anomaly in the Earth's magnetic field portend a coming pole reversal?
Immunotherapy: Training the body to fight cancer
Do vegetarians live longer? Probably, but not because they're vegetarian
Could a contraceptive app be as good as the pill?
Some scientific explanations for alien abduction that aren't so out of this world
Society actually does want policies that benefit future generations
Six cosmic catastrophes that could wipe out life on Earth
Big Pharma Starts Using Cannabis For Making Drugs In Earnest
Do you need to worry if your baby has a flat head?
Go here to see the original:
TiGenix to present at Cowen's 37th Annual Health Care Conference in Boston - EconoTimes
- The Beating Heart (Cardiac) Cells [Last Updated On: June 24th, 2011] [Originally Added On: June 24th, 2011]
- cellalign [Last Updated On: June 24th, 2011] [Originally Added On: June 24th, 2011]
- Okamoto placenta-derived cardiomyocytes [Last Updated On: June 25th, 2011] [Originally Added On: June 25th, 2011]
- Cardiac Stem Cell Therapy [Last Updated On: June 26th, 2011] [Originally Added On: June 26th, 2011]
- Wow! UW Research labs [Last Updated On: June 26th, 2011] [Originally Added On: June 26th, 2011]
- Cardiac Stem Cell Therapy [Last Updated On: June 28th, 2011] [Originally Added On: June 28th, 2011]
- cellalign [Last Updated On: July 3rd, 2011] [Originally Added On: July 3rd, 2011]
- Insidermedicine In 60 - August 4, 2011 [Last Updated On: August 25th, 2011] [Originally Added On: August 25th, 2011]
- Cardiac Stem Cells in End-Stage Human Failing Hearts: Are they functional? [Last Updated On: August 28th, 2011] [Originally Added On: August 28th, 2011]
- Did you have a Heart Attack and Need to Recover your Cardiac Muscle? [Last Updated On: September 5th, 2011] [Originally Added On: September 5th, 2011]
- Heart repair using own stem cells after heart attack: Future Health keynote speaker [Last Updated On: September 5th, 2011] [Originally Added On: September 5th, 2011]
- Cardiac Stem Cell Therapy at Rostock University [Last Updated On: September 5th, 2011] [Originally Added On: September 5th, 2011]
- Cardiovascular Therapies: Spotlight on Stem Cell Research - Douglas Boyd [Last Updated On: September 5th, 2011] [Originally Added On: September 5th, 2011]
- Davos Question: Stem Cell Answer [Last Updated On: September 5th, 2011] [Originally Added On: September 5th, 2011]
- Stem Cell operation in Cardiac Surgery-Al-Jazeerah [Last Updated On: September 6th, 2011] [Originally Added On: September 6th, 2011]
- Stem Cell Therapy in Cardiac Disease [Last Updated On: September 6th, 2011] [Originally Added On: September 6th, 2011]
- Designer Life: repair brain, heart with stem cells - Future Health keynote speaker [Last Updated On: September 7th, 2011] [Originally Added On: September 7th, 2011]
- Stem Cells: Mending a broken heart? [Last Updated On: September 7th, 2011] [Originally Added On: September 7th, 2011]
- Cardiac Stem Cells in End-Stage Human Failing Hearts: Are they functional? [Last Updated On: September 8th, 2011] [Originally Added On: September 8th, 2011]
- Oral Surgeon utilizes StemSave to preserve stem cells in wisdom teeth to combat cardiac disease [Last Updated On: September 9th, 2011] [Originally Added On: September 9th, 2011]
- Cardiac Recovery Points to Adult Stem Cells [Last Updated On: September 9th, 2011] [Originally Added On: September 9th, 2011]
- Oral Surgeon utilizes StemSave to preserve stem cells in wisdom teeth to combat cardiac disease [Last Updated On: September 10th, 2011] [Originally Added On: September 10th, 2011]
- Stem Cell operation in Cardiac Surgery-Al-Jazeerah [Last Updated On: September 10th, 2011] [Originally Added On: September 10th, 2011]
- Cardiovascular Derivatives of Embryonic Stem Cells in Cardiac Repair and Drug Discovery [Last Updated On: September 10th, 2011] [Originally Added On: September 10th, 2011]
- Stem Cell Therapy in Cardiac Disease [Last Updated On: September 11th, 2011] [Originally Added On: September 11th, 2011]
- Cardiovascular Derivatives of Embryonic Stem Cells in Cardiac Repair and Drug Discovery [Last Updated On: September 12th, 2011] [Originally Added On: September 12th, 2011]
- Stem Cells and Cardiac Regeneration [Last Updated On: September 12th, 2011] [Originally Added On: September 12th, 2011]
- Cardiomyogenic differentiation of Mesenchymal Stem cells (KUM2/9-15c) [Last Updated On: September 12th, 2011] [Originally Added On: September 12th, 2011]
- Mark Mercola: Differentiating embryonic stem cells into adult tissues [Last Updated On: September 15th, 2011] [Originally Added On: September 15th, 2011]
- Cardiovascular Therapies: Spotlight on Stem Cell Research - Douglas Boyd [Last Updated On: September 20th, 2011] [Originally Added On: September 20th, 2011]
- Stem Cell #8 Vas Cath Removal 04/28/11 [Last Updated On: September 20th, 2011] [Originally Added On: September 20th, 2011]
- Adult Stem Cells Used To Rebuild Heart Tissue Video. More at http://www.stemcellfusion.com [Last Updated On: September 20th, 2011] [Originally Added On: September 20th, 2011]
- Stem Cell Therapy and Stem Cell Treatment with Dell [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- First US Patient In Stem Cell Transplant [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Stem Cell Heart Surgery must see [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Beating cardiac myocytes from differentiated mouse iPSC. [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- heart cell generation from human ES and iPS cells (embryonic and induced pluripotent stem cells).flv [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Advanced Cell Technology OneMedForum 2011 [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- 20100804_axiogenesis.wmv [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Pt. 1--Dr. Ali Denktas--Stem Cells as Markers after Myocardial Infarctions [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Cardiac Tissue Can Regenerate [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Adult Stem Cell [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Beating cardiomyocyte monolayer [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Valentine's Day Stem Cell Wish: Mending Broken Hearts [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Cardiomyocytes derived from mouse Embryonic stem cells [Last Updated On: September 24th, 2011] [Originally Added On: September 24th, 2011]
- UCD Med Student Receives Fulbright Award [Last Updated On: September 24th, 2011] [Originally Added On: September 24th, 2011]
- Mouse GEN cells overexpressing Csx/Nkx2.5 and GATA4 behave like transient amplifying cells [Last Updated On: September 24th, 2011] [Originally Added On: September 24th, 2011]
- 2010 - 2011 UConn Highlight Reel [Last Updated On: September 24th, 2011] [Originally Added On: September 24th, 2011]
- William F. Testimonial of Treatment Stem Cell [Last Updated On: September 24th, 2011] [Originally Added On: September 24th, 2011]
- BeatingCM_on_MEA.wmv [Last Updated On: September 24th, 2011] [Originally Added On: September 24th, 2011]
- Breakthrough in Stem cell technology [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- stem cell derived cardiomyocytes [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Mark Mercola: Differentiating embryonic stem cells into adult tissues [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Cadiomyogenesis of human mesenchymal stem cells [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Adult Stem Cell vs Embryonic Stem Cell Research Ethics Video [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Heart Failure Patient After Adult Stem Cell Therapy [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Affordable Stem Cell Therapy in Guatemala (2hrs from Miami) [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Kevin's 2 Heart Transplants and Stem Cell Transplant [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Immune Control of Stem Cell Mobilization [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Patel Stem Cell Heart Failure [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Better Drugs Through Stem Cells [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Heart Disease Patient Describes His Stem Cell Treatment [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Turning Adult Stem Cells into Medicine - Zannos Grekos, MD [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Cardiomyocytic differentiation of endometrial stem cells. [Last Updated On: September 26th, 2011] [Originally Added On: September 26th, 2011]
- Turning Adult Stem Cells into Medicine - Zannos Grekos, MD [Last Updated On: September 26th, 2011] [Originally Added On: September 26th, 2011]
- Stem Cells: Heart cells grown from mouse stem cells [Last Updated On: September 26th, 2011] [Originally Added On: September 26th, 2011]
- Beating cells [Last Updated On: September 28th, 2011] [Originally Added On: September 28th, 2011]
- Repairing Damaged Hearts with Stem Cells [Last Updated On: September 28th, 2011] [Originally Added On: September 28th, 2011]
- Heart cells grown from human embryonic stem cells [Last Updated On: September 28th, 2011] [Originally Added On: September 28th, 2011]
- CytoTune iPSCs - Cardiomyocytes [Last Updated On: September 29th, 2011] [Originally Added On: September 29th, 2011]
- Becoming Bionic: The Little Book of Hope for Heart Patients Runblog ("Dress the Part") [Last Updated On: September 29th, 2011] [Originally Added On: September 29th, 2011]
- H9 Cardiac EBs.mov [Last Updated On: September 29th, 2011] [Originally Added On: September 29th, 2011]
- Beating Cardiomyocytes from E14 Cells [Last Updated On: September 29th, 2011] [Originally Added On: September 29th, 2011]
- Human 2.0: The Helix of Our Future [Last Updated On: September 30th, 2011] [Originally Added On: September 30th, 2011]
- Beating Human Heart Cells from Embryonic Stem Cells [Last Updated On: October 1st, 2011] [Originally Added On: October 1st, 2011]
- Be still my beating stem cell heart [Last Updated On: October 1st, 2011] [Originally Added On: October 1st, 2011]
- Doctors To Use 'Trained' Stem Cells To Heal Heart [Last Updated On: October 2nd, 2011] [Originally Added On: October 2nd, 2011]
- Spontaneously and rhythmically beating engineered human heart tissue from pluripotent stem cells [Last Updated On: October 3rd, 2011] [Originally Added On: October 3rd, 2011]
- Cardiac Stem Cell Therapy - How it works [Last Updated On: October 4th, 2011] [Originally Added On: October 4th, 2011]
- Doctors To Use 'Trained' Stem Cells To Heal Heart [Last Updated On: October 4th, 2011] [Originally Added On: October 4th, 2011]